Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: Outcomes based on american joint committee on cancer classification

Archives of Ophthalmology

Volumn 130, Issue 2, 2012, Pages 159-164

  Shah, Sanket U ^a   Kaliki, Swathi ^a   Kim, H Jane ^a   Lally, Sara E ^a   Shields, Jerry A ^a   Shields, Carol L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON;

ACANTHOMA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CONJUNCTIVA TUMOR; CONJUNCTIVAL HYPEREMIA; CONJUNCTIVAL INTRAEPITHELIAL NEOPLASIA; CORNEA DISEASE; CORNEA EPITHELIAL DEFECT; CRYOTHERAPY; DRUG EFFICACY; DRUG WITHDRAWAL; EYE CANCER; EYE DISEASE; EYE IRRITATION; FEMALE; FLU LIKE SYNDROME; FOLLICULAR HYPERTROPHY; GIANT PAPILLARY CONJUNCTIVITIS; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OCULAR SURFACE SQUAMOUS NEOPLASIA; PRIORITY JOURNAL; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CONJUNCTIVAL NEOPLASMS; CORNEAL DISEASES; EYE NEOPLASMS; FEMALE; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; REMISSION INDUCTION; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 84863130016     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.385     Document Type: Article

References (36)

1. Shields JA, Shields CL. Premalignant and malignant lesions of the conjunctival epithelium. In: Shields JA, Shields CL, eds. Eyelid, Conjunctival, and Orbital Tumor: An Atlas and Textbook. Philadelphia, PA: Lippincott Williams & Wilkins Co; 2008:286-305.
2. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995; 39(6):429-450.
3. Kiire CA, Srinivasan S, Karp CL. Ocular surface squamous neoplasia. Int Ophthalmol Clin. 2010;50(3):35-46.
4. Shields JA, Shields CL, Gunduz K, Eagle RC Jr. The 1998 Pan American Lecture: intraocular invasion of conjunctival squamous cell carcinoma in five patients. Ophthal Plast Reconstr Surg. 1999;15(3):153-160. (Pubitemid 30438876)
5. Rao NA, Font RL.Mucoepidermoid carcinoma of the conjunctiva: a clinicopathologic study of five cases. Cancer. 1976;38(4):1699-1709.
6. Shields CL, Demirci H, Karatza E, Shields JA. Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology. 2004;111(9): 1747-1754. (Pubitemid 39179692)
7. Shields CL, Shields JA. Tumors of the conjunctiva and cornea. Surv Ophthalmol. 2004;49(1):3-24. (Pubitemid 38056621)
8. Sun EC, Fears TR, Goedert JJ. Epidemiology of squamous cell conjunctival cancer. Cancer Epidemiol Biomarkers Prev. 1997;6(2):73-77. (Pubitemid 27069198)
9. Scott IU, Karp CL, Nuovo GJ. Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia. Ophthalmology. 2002;109(3):542-547. (Pubitemid 34184924)
10. Spitzer MS, Batumba NH, Chirambo T, et al. Ocular surface squamous neoplasia as the first apparent manifestation of HIV infection in Malawi. Clin Experiment Ophthalmol. 2008;36(5):422-425.
11. Napora C, Cohen EJ, Genvert GI, et al. Factors associated with conjunctival intraepithelial neoplasia: a case control study. Ophthalmic Surg. 1990;21(1):27-30. (Pubitemid 20115722)
12. Ramasubramanian A, Shields CL, Sinha N, Shields JA. Ocular surface squamous neoplasia after corneal graft. Am J Ophthalmol. 2010;149(1):62-65.
13. Shields CL, Ramasubramanian, Mellen PL, Shields JA. Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection) [published online July 13, 2011]. Ophthalmology.
14. Giaconi JA, Karp CL. Current treatment options for conjunctival and corneal intraepithelial neoplasia. Ocul Surf. 2003;1(2):66-73. (Pubitemid 41263906)
15. Sepulveda R, Pe'er J, Midena E, Seregard S, Dua HS, Singh AD. Topical chemotherapy for ocular surface squamous neoplasia: current status. Br J Ophthalmol. 2010;94(5):532-535.
16. Poothullil AM, Colby KA. Topical medical therapies for ocular surface tumors. Semin Ophthalmol. 2006;21(3):161-169. (Pubitemid 44266790)
17. Hirst LW. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution. Ophthalmology. 2007;114(5):976-982. (Pubitemid 46635832)
18. Shields CL, Demirci H, Marr BP, Masheyekhi A, Materin M, Shields JA. Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva. Arch Ophthalmol. 2005;123(1):109-113. (Pubitemid 40105441)
19. Yeatts RP, Engelbrecht NE, Curry CD, Ford JG, Walter KA. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology. 2000;107(12):2190-2195.
20. Galor A, Karp CL, Chhabra S, Barnes S, Alfonso EC. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Br J Ophthalmol. 2010;94(5):551-554.
21. Schechter BA, Koreishi AF, Karp CL, Feuer W. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b. Ophthalmology. 2008;115(8):1291-1296.
22. Sturges A, Butt AL, Lai JE, Chodosh J. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Ophthalmology. 2008;115(8):1297-1302.
23. Huerva V, Mangues I. Treatment of conjunctival squamous neoplasias with interferon alpha 2ab. J Fr Ophtalmol. 2008;31(3):317-325.
24. Holcombe DJ, Lee GA. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia. Am J Ophthalmol. 2006;142(4):568-571.
25. Boehm MD, Huang AJ. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Ophthalmology. 2004;111(9): 1755-1761. (Pubitemid 39179693)
26. Schechter BA, Schrier A, Nagler RS, Smith EF, Velasquez GE. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Cornea. 2002;21(1):6-11. (Pubitemid 33144395)
27. Karp CL, Moore JK, Rosa RH Jr. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology. 2001;108 (6):1093-1098. (Pubitemid 32500027)
28. Edge SB, Byrd DR, Compton CC, eds, et al. Carcinoma of the conjunctiva. In: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010:531-537.
29. Baron S, Tyring SK, Fleischmann WR Jr, et al. The interferons: mechanisms of action and clinical applications. JAMA. 1991;266(10):1375-1383.
30. Intron A. Product information: Intron® A interferon alfa-2b, recombinant for injection. http://www.spfiles.com/piintrona.pdf. Accessed January 24, 2011.
31. Gangemi JD, Pirisi L, Angell M, Kreider JW. HPV replication in experimental models: effects of interferon. Antiviral Res. 1994;24(2-3):175-190. (Pubitemid 24228873)
32. Majewski S, Szmurlo A, Marczak M, Jablonska S, Bollag W. Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines. Int J Cancer. 1994;57(1):81-85. (Pubitemid 24117104)
33. Esquenazi S, Fry CL, Holley E. Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b. Br J Ophthalmol. 2005;89(9): 1221. doi:10.1136/bjo.2004.063339. (Pubitemid 41224479)
34. Smith M, Trousdale MD, Rao NA, Robin JB. Lack of toxicity of a topical recombinant interferon alpha. Cornea. 1989;8(1):58-61. (Pubitemid 19081293)
35. de Keizer RJ, de Wolff-Rouendaal D. Topical alpha-interferon in recurrent conjunctival papilloma. Acta Ophthalmol Scand. 2003;81(2):193-196. (Pubitemid 36609225)
36. Stone DU, Butt AL, Chodosh J. Ocular surface squamous neoplasia: a standard of care survey. Cornea. 2005;24(3):297-300. (Pubitemid 40418339)